Spectrum


Spectrum Pharmaceuticals’ (SPPI) Encouraging Clinical Update in NSCLC Gets the Bulls in a Buying Frenzy

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) just riled up Wall Street today with enticing Phase 2 study results in non-small cell lung cancer (NSCLC), sending …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts